Genetic Diversity of Mycobacterium tuberculosis in Peru and Exploration of Phylogenetic Associations with Drug Resistance

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Sheen, Patricia ^a   Couvin, David ^b   Grandjean, Louis ^a,c,d   Zimic, Mirko ^a   Dominguez, Maria ^a   Luna, Giannina ^a   Gilman, Robert H ^a,d,e   Rastogi, Nalin ^b   Moore, David A J ^a,c,d,e  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b Institut Pasteur de Guadeloupe   (Guadeloupe)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; CLADISTICS; CONTROLLED STUDY; FEMALE; GENE CLUSTER; GENETIC ASSOCIATION; GENETIC VARIABILITY; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERU; PHYLOGENETIC TREE;

ADULT; ANTITUBERCULAR AGENTS; DIRECTLY OBSERVED THERAPY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; ISONIAZID; MALE; MYCOBACTERIUM TUBERCULOSIS; PERU; PHYLOGENY; RIFAMPIN; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84879486304     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065873     Document Type: Article

References (12)

1. Demay C, Liens B, Burguiere T, Hill V, Couvin D, et al. (2012) SITVITWEB-a publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infect Genet Evol 12: 755-766.
2. Taype CA, Agapito JC, Accinelli RA, Espinoza JR, Godreuil S, et al. (2012) Genetic diversity, population structure and drug resistance of Mycobacterium tuberculosis in Peru. Infect Genet Evol 12: 577-585.
3. Suarez PG, Watt CJ, Alarcon E, Portocarrero J, Zavala D, et al. (2001) The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru. J Infect Dis 184: 473-478.
4. Kawai V, Soto G, Gilman RH, Bautista CT, Caviedes L, et al. (2006) Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru. Am J Trop Med Hyg 75: 1027-1033.
5. Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, et al. (2006) Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 355: 1539-1550.
6. Moore DA, Mendoza D, Gilman RH, Evans CA, Hollm Delgado MG, et al. (2004) Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol 42: 4432-4437.
7. Tang C, Reyes JF, Luciani F, Francis AR, Tanaka MM, (2008) spolTools: online utilities for analyzing spoligotypes of the Mycobacterium tuberculosis complex. Bioinformatics 24: 2414-2415.
8. Reyes JF, Francis AR, Tanaka MM, (2008) Models of deletion for visualizing bacterial variation: an application to tuberculosis spoligotypes. BMC Bioinformatics 9: 496.
9. Ellson J, Gansner E, Koutsofios L, North SC, Woodhull G (2002) Graphviz- Open Source Graph Drawing Tools. In: Mutzel P, Jünger M, Leipert S, editors. Heidelberg: Springer-Verlag Berlin. pp. 483-484.
10. Iwamoto T, Grandjean L, Arikawa K, Nakanishi N, Caviedes L, et al. (2012) Genetic diversity and transmission characteristics of Beijing family strains of Mycobacterium tuberculosis in Peru. PLoS One 7: e49651.
11. Zignol M, van Gemert W, Falzon D, Sismanidis C, Glaziou P, et al. (2012) Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull World Health Organ 90: 111-119D.
12. Svensson E, Millet J, Lindqvist A, Olsson M, Ridell M, et al. (2011) Impact of immigration on tuberculosis epidemiology in a low-incidence country. Clin Microbiol Infect 17: 881-887.